In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target.

Murakami S, Barroca V, Perié L, Bravard A, Bernardino-Sgherri J, Tisserand A, Devanand C, Edmond V, Magniez A, Tenreira Bento S, Torres C, Pasquier F, Plo I, Vainchenker W, Villeval JL, Roméo PH, Lewandowski D

Open source

DOI: 10.1158/2643-3230.bcd-21-0039
Published: 2022 Jul 6
Container: Blood cancer discovery
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/2643-3230.bcd-21-0039,
  title = {In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target.},
  author = {Murakami S and Barroca V and Perié L and Bravard A and Bernardino-Sgherri J and Tisserand A and Devanand C and Edmond V and Magniez A and Tenreira Bento S and Torres C and Pasquier F and Plo I and Vainchenker W and Villeval JL and Roméo PH and Lewandowski D},
  year = {2022},
  journal = {Blood cancer discovery},
  doi = {10.1158/2643-3230.bcd-21-0039},
  url = {https://doi.org/10.1158/2643-3230.bcd-21-0039}
}

RIS

TY  - JOUR
TI  - In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target.
AU  - Murakami S
AU  - Barroca V
AU  - Perié L
AU  - Bravard A
AU  - Bernardino-Sgherri J
AU  - Tisserand A
AU  - Devanand C
AU  - Edmond V
AU  - Magniez A
AU  - Tenreira Bento S
AU  - Torres C
AU  - Pasquier F
AU  - Plo I
AU  - Vainchenker W
AU  - Villeval JL
AU  - Roméo PH
AU  - Lewandowski D
PY  - 2022
JO  - Blood cancer discovery
DO  - 10.1158/2643-3230.bcd-21-0039
UR  - https://doi.org/10.1158/2643-3230.bcd-21-0039
ER  -

APA

S, M., V, B., L, P., A, B., J, B., A, T., C, D., V, E., A, M., S, T. B., C, T., F, P., I, P., W, V., JL, V., PH, R., & D, L. (2022). In Vivo Monitoring of Polycythemia Vera Development Reveals Carbonic Anhydrase 1 as a Potent Therapeutic Target.. Blood cancer discovery. https://doi.org/10.1158/2643-3230.bcd-21-0039

Source records

pubmed · retrieved 2026-09-26T00:18:52.050Z